Expressing support for the designation of September 2026 as “National Polycystic Kidney Disease Awareness Month”, and raising awareness and understanding of polycystic kidney disease.
Latest action (1 Oct 2026): Introduced
What this bill does
This resolution, H.Res. 1595, expresses the House of Representatives' support for designating September 2026 as "National Polycystic Kidney Disease Awareness Month." The bill aims to increase public understanding of polycystic kidney disease (PKD), a genetic disorder affecting kidneys and other organs. It highlights that PKD is a leading cause of kidney failure, with many individuals developing it spontaneously.
The resolution acknowledges that PKD impacts approximately 500,000 people in the United States, regardless of age, race, ethnicity, or sex. It also notes the limited treatment options and the potential for serious health complications, including kidney failure for nearly half of those diagnosed by age 60. The bill mentions the role of caregivers and the importance of regular medical visits.
H.Res. 1595 was introduced in the House of Representatives on October 1, 2026, by Representative Emanuel Cleaver and co-sponsored by Representative Graves. It has been referred to the Committee on Energy and Commerce. As a resolution, its passage in the House does not require Senate approval or the President's signature to take effect; it serves as an official expression of the House's stance.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This resolution is in the first stage of the legislative process. It was introduced into Congress on October 1, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does H.Res. 1595 do?
- This resolution, H.Res. 1595, expresses the House of Representatives' support for designating September 2026 as "National Polycystic Kidney Disease Awareness Month." The bill aims to increase public understanding of polycystic kidney disease (PKD), a genetic disorder affecting kidneys and other organs. It highlights that PKD is a leading cause of kidney failure, with many individuals developing it spontaneously. The resolution acknowledges that PKD impacts approximately 500,000 people in the United States, regardless of age, race, ethnicity, or sex. It also notes the limited treatment options and the potential for serious health complications, including kidney failure for nearly half of those diagnosed by age 60. The bill mentions the role of caregivers and the importance of regular medical visits. H.Res. 1595 was introduced in the House of Representatives on October 1, 2026, by Representative Emanuel Cleaver and co-sponsored by Representative Graves. It has been referred to the Committee on Energy and Commerce. As a resolution, its passage in the House does not require Senate approval or the President's signature to take effect; it serves as an official expression of the House's stance.
- Has H.Res. 1595 become law?
- Not yet. As of 1 Oct 2026, H.Res. 1595 is introduced.
- Who sponsored H.Res. 1595?
- H.Res. 1595 was sponsored by Rep. Emanuel Cleaver [D-MO5] (Democrat-MO), with 0 cosponsors.
- What's the latest action on H.Res. 1595?
- Introduced (1 Oct 2026).
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.